Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174348 | SCV000225634 | other | not provided | 2017-01-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000433699 | SCV000519510 | benign | not specified | 2016-04-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000433699 | SCV000539721 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 528/13006=4.05% |
ARUP Laboratories, |
RCV000174348 | SCV000604290 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001516074 | SCV001724288 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001516074 | SCV001737365 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000174348 | SCV005284369 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001516074 | SCV001455748 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000433699 | SCV001925583 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000433699 | SCV001953557 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003965255 | SCV004791721 | likely benign | MTHFR-related disorder | 2020-07-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |